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Background: Left atrial volume (LAV) and exercise capacity are important prognostic determinants of
cardiovascular risk. Exercise intolerance and increased LAV are expected in patients with diastolic dysfunction. While
dyspnea is the symptom reported by the patient and considered subjective, exercise capacity obtained by exercise
testing provides an objective measure of cardiovascular fitness. The objective of this study is to determine the
relationship between LAV index and exercise capacity in patients with isolated diastolic dysfunction who presented
with exertional dyspnea.
Methods: We studied consecutive patients with dyspnea who underwent treadmill exercise testing and
transthoracic echocardiography on the same day. LAV was assessed using the biplane area-length method.
Symptom-limited exercise testing was performed immediately after echocardiography. Patients with coronary artery
disease, valvular or congenital heart disease, left ventricular systolic dysfunction, pulmonary hypertension or positive
exercise test were excluded.
Results: The study consisted of 111 patients (58.1 ± 9.2 years of age, 54.1% male, 64% hypertension, 57.7%
dyslipidemia and 20.7% diabetes). The exercise duration and capacity were 6.8 ± 2.1 minutes and 7.7 ± 1.9 METs,
respectively. Left ventricular ejection fraction and LAV index was 71.0 ± 5.8% and 31.4 ± 10.5 ml/m2, respectively. In
multivariate analysis, age [odds ratios (OR) 0.94; 95% confidence interval (CI) 0.89-0.99], body mass index (OR 0.82,
95% CI 0.72-0.93), and LAV index (OR 0.92, 95% CI 0.87-0.97) were associated with good exercise capacity.
Conclusion: In patients with isolated diastolic dysfunction and exertional dyspnea, an increased LAV index, a
marker of chronic diastolic dysfunction, is associated with poor exercise capacity.
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Exercise capacity has been known to be an important
prognostic determinant of cardiovascular and overall mor-
tality [1,2]. The peak exercise capacity achieved dur-
ing exercise testing is even more powerful than other
established risk factors for cardiovascular disease such
as hypertension, smoking, and diabetes mellitus [1].
Dyspnea is a classic symptom of heart failure. However, it
is a subjective symptom with multiple potential etiologies,* Correspondence: nithima.cha@mahidol.ac.th
1Division of Cardiology, Department of Medicine, Siriraj Hospital, Mahidol
University, Bangkok 10700, Thailand
Full list of author information is available at the end of the article
© 2014 Ratanasit et al.; licensee BioMed Centr
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.not solely due to increased filling pressure. It may be
a manifestation of diastolic dysfunction or other non-
cardiac conditions, such as pulmonary disease, obesity,
anemia, endocrine disorders, physical deconditioning, or
psychological disorder, and may as well limit exercise tol-
erance. Several studies have provided data on the signifi-
cance of left ventricular (LV) diastolic dysfunction. The
number of patients with heart failure in the presence of
preserved systolic function was reported in 30-40% and
LV diastolic dysfunction may be the underlying cause of
symptoms in such patients [3]. While dyspnea is the sub-
jective symptom reported by the patient, exercise capacity
obtained by exercise testing provides an objective measureal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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fitness. Poor physical fitness is a modifiable risk factor,
and the improvement in cardiovascular fitness has been
demonstrated to improve prognosis [4].
Previous studies have shown that LV diastolic function
is an important determinant of exercise capacity in nor-
mal individuals and patients with various heart diseases
[5-10]. The assessment of LV diastolic function can be
performed noninvasively by the conventional echocar-
diography and tissue Doppler imaging (TDI). Left atrial
volume (LAV) has been recognized as an indicator of
chronic diastolic dysfunction [11,12]. Increased LAV has
been shown to be associated with cardiovascular risk
burden and an increased risk of atrial fibrillation, stroke,
heart failure and death [11-14]. Therefore, we hypothe-
sized that an increased LAV and some echocardiographic
indices of LV diastolic dysfunction would correlate with




Patients with the complaint of shortness of breath who
were referred for treadmill exercise testing and trans-
thoracic echocardiography at Siriraj Hospital were pro-
spectively enrolled in the study. The exercise testing
was performed immediately after the echocardiographic
examination. Eligible patients were adults patients, in
sinus rhythm, and able to exercise on the treadmill. The
patients with known coronary artery disease, history of
clinical heart failure, moderate or severe valvular heart
disease, congenital heart disease, history of coronary re-
vascularization or any prior cardiac surgery, LV systolic
dysfunction (ejection fraction < 50%), significant pul-
monary hypertension (right ventricular systolic pressure >
50 mmHg), end-stage renal disease waiting for renal trans-
plantation, pulmonary, hepatic or hematologic diseases
were excluded from the study. The positive result of tread-
mill exercise testing and the echocardiographic detection
of regional wall motion abnormality were also the exclu-
sion criteria. The institutional review board of Siriraj Hos-
pital approved the study protocol. Informed consent was
obtained from all patients.
Echocardiography
Each participant underwent a comprehensive transthoracic
echocardiographic examination with two-dimensional,
M-mode, Doppler echocardiography and TDI. The meas-
urement of echocardiographic parameters was performed
on 3–5 consecutive cardiac cycles and the average was
used for the analysis. The LV end-systolic and end-
diastolic dimensions and wall thickness were measured
using M-mode tracing. The LV end-systolic and end-
diastolic volume and LV ejection fraction were determinedusing the Modified Simpson’s rule (biplane) [15]. The LV
diastolic function was assessed by Doppler echocardiog-
raphy of transmitral flow velocities and TDI of the mitral
annulus. Peak early (E) and late (A) diastolic velocities of
mitral inflow and deceleration time of E were measured
using pulsed-wave Doppler with the sample volume at the
tip of mitral valve. The TDI determination of diastolic
function was performed in apical 4-chamber view with
the sample volume at the septal aspect of mitral annulus.
Longitudinal early (E’) and late (A’) diastolic myocardial
velocities were measured. The E/A and E/E’ ratio were
calculated. Left atrial (LA) dimension was measured by
M-mode echocardiography from the parasternal short-
axis view at end-systole. LAV was determined using the
biplane area-length method and LV mass was calculated
as recommended by the American Society of Echocardi-
ography [15]. LAV and LV mass were indexed for body
surface area. LA enlargement was defined as LAV index ≥
29 ml/m2 as recommended by the American Society of
Echocardiography [15]. Similarly, in the present study, the
best cutoff value of LAV index for predicting good exer-
cise capacity from the receiver operating characteristic
curve (ROC) analysis was 29 ml/m2.
Treadmill exercise testing
Symptom-limited treadmill exercise testing with the Bruce
protocol was performed to assess the patients’ maximal
exercise capacity. All patients were encouraged to exercise
to maximal effort. The physician who was unaware of
the echocardiographic results was present during exercise
testing. Patients were instructed to continue their current
medications on the day of testing. The predetermined end
points of exercise testing were a positive test or maximal
exercise capacity. Heart rate was recorded from a continu-
ous 12-lead ECG monitoring. The age-predicted maximal
heart rate was calculated as 220-age. Target heart rate was
defined as 85% of the age-predicted maximal heart rate.
The exercise time was recorded. Maximal exercise cap-
acity was defined by the achieved metabolic equivalents
(METs), which equal 3.5 mL of oxygen uptake per kilo-
gram of body weight per minute and was estimated from
exercise time as METs = 1.1 + (0.016 × exercise time in
seconds) [16]. Patients with good exercise capacity were
defined as those achieved ≥ 7 METs [16]. Rate pressure
product was calculated as the product of heart rate and
systolic blood pressure at peak exercise.
Statistical analysis
Clinical, exercise and echocardiographic data were des-
cribed using descriptive statistics, including means, stan-
dard deviation, number and percentage. The Student’s t-
test was used to compare continuous variables between
2 groups of patients. Comparison of categorical varia-
bles was performed using the Chi-square test. The ROC
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LAV index for predicting good exercise capacity. Univari-
ate binary logistic regression analysis was used to assess
the relationship between good exercise capacity and other
variables. Multiple binary logistic regression analysis was
performed using metabolic equivalent (good exercise cap-
acity) as the dependent variable. Risk factors or independ-
ent variables (age in years, body mass index, peak heart
rate, LA diameter, LAV index, A, E’, E/E’, LV mass index)
were selected on the basis of clinical and statistical sig-
nificances. The model was fitted by backward stepwise
method for variable selection in and out of the model. All
p-values are reported as 2-tailed, except where otherwise
indicated. A p-value of ≤ 0.05 was considered statistically
significant. Statistical analyses were performed using SPSS
statistical package version 18.0.
Results
The study consisted of 111 patients (58.1 ± 9.2 years of
age, 54.1% male). LA enlargement was observed in 59
(53.2%) patients. The patients were classified into 2 groups
according to the presence of LA enlargement. Clinical
characteristics in all patients and patients grouped accor-
ding to the presence of LA enlargement are shown in
Table 1. Patients with LA enlargement were significantly
older. However, gender, body mass index, coronary risk
factors and current medications were not significantly dif-
ferent between the 2 groups.
Echocardiographic data
All patients had good LV systolic function with LV ejec-
tion fraction of 71.0 ± 5.8%. The right ventricular systolicTable 1 Clinical characteristics of all patients and the









Age (years) 58.1 ± 9.2 55.9 ± 8.8 60.1 ± 9.2 0.018
Male gender 60 (54.1) 30 (57.7) 30 (50.8) 0.470
BMI (kg/m2) 25.7 ± 3.8 25.6 ± 3.3 25.7 ± 4.1 0.960
Hypertension 71 (64.0) 31 (59.6) 40 (67.8) 0.370
Diabetes
mellitus
23 (20.7) 9 (17.3) 14 (23.7) 0.405
Smoking 9 (8.1) 5 (9.6) 4 (6.8) 0.732
Dyslipidemia 64 (57.7) 33 (63.5) 31 (52.5) 0.245
Betablocker 50 (45.0) 22 (42.3) 28 (47.5) 0.586
ACEI/ARB 40 (36.0) 19 (37.3) 21 (35.6) 0.857
Diuretics 9 (8.1) 3 (5.7) 6 (10.2) 0.503
Data are expressed as mean ± standard deviation and number (percentage).
P values are for comparisons between 2 groups.
ACEI/ARB = Angiotensin converting enzyme inhibitor/angiotensin receptor
blocker; BMI = Body mass index; LAVI = Left atrial volume index.pressure was 31.7 ± 6.5 mmHg. All patients had diastolic
dysfunction; abnormal relaxation and pseudonormaliza-
tion pattern in 64.9% and 35.1%, respectively. No patient
had an advanced stage of diastolic dysfunction (restric-
tive filling pattern). LAV index and LV mass index were
31.4 ± 10.5 ml/m2 and 110.2 ± 40.1 gm/m2, respectively.
The echocardiographic data are present in Table 2. Pa-
tients with LA enlargement significantly presented with
more LV hypertrophy, larger LV end-diastolic dimension
and volume, and more severe diastolic dysfunction (lower
E’ and higher E/E’) than those without.
Exercise hemodynamics
The results of exercise testing are presented in Table 3.
Achieving target heart rate was reported in 57.7% of pa-
tients. More patients without LA enlargement achieved
target heart rate than those with LA enlargement (69.2%
vs. 47.5%, p = 0.021). Regarding exercise capacity, the
number of patients who achieved target heart rate was
similar between those with and without good exercise
capacity (60.3% vs. 52.6%, p = 0.439). Good exercise cap-
acity was reported in 65.8% of patients. More patients
without LA enlargement had good exercise capacity than
those with LA enlargement (82.7% vs. 50.8%, p < 0.001).
The absolute exercise capacity was significantly better in
patients without LA enlargement (8.3 ± 1.7 vs. 7.3 ± 2.0,
p = 0.005). No serious complication occurred during tread-
mill exercise testing.
Determinants of exercise capacity
Regarding exercise capacity, the patients were further
categorized as those with and without good exercise cap-
acity. Table 4 shows the clinical, exercise and echocardio-
graphic parameters of all patients and the comparisons
between patients with and without good exercise capacity.
There were no statistically significant differences between
patients with and without good exercise capacity in term
of the number of male gender, hypertension, diabetes mel-
litus, dyslipidemia, smoking, rest and peak systolic and
diastolic blood pressure, and grade of diastolic dysfunc-
tion. The results of univariate and multivariate binary lo-
gistic regression analysis are shown in Table 5. LAV index
remained an independent predictor of good exercise ca-
pacity. In univariate analysis, age, body mass index, peak
heart rate, A, E’, E/E’ ratio, LA dimension, LV mass index
and LAV index showed a significant association with good
exercise capacity. By multiple logistic regression analysis,
age [odds ratios (OR) 0.94; 95% confidence interval (CI)
0.89-0.99], body mass index (OR 0.82, 95% CI 0.72-0.93),
and LAV index (OR 0.92, 95% CI 0.87-0.97) were associ-
ated with good exercise capacity (Table 5). In the present
study, the cutoff value of LAV index of 29 ml/m2 pre-
dicted good exercise capacity with the sensitivity, specifi-
city, predictive accuracy of positive and negative results of
Table 2 Echocardiographic parameters of all patients and the comparisons between patients with and without left
atrial enlargement
Variables Total (n = 111) LAVI < 29 ml/m2 (n = 52) LAVI ≥ 29 ml/m2 (n = 59) P-value
LVDD (mm) 48.2 ± 4.8 47.1 ± 3.7 49.1 ± 5.4 0.026
LVSD (mm) 27.9 ± 5.3 27.7 ± 4.3 28.0 ± 6.0 0.814
IVSd (mm) 10.9 ± 2.6 10.3 ± 2.4 11.4 ± 2.7 0.025
LVEDV (ml) 68.8 ± 16.6 65.0 ± 13.9 72.1 ± 18.1 0.023
LVESV (ml) 20.2 ± 8.0 19.4 ± 7.5 20.8 ± 8.4 0.380
LV ejection fraction (%) 71.1 ± 5.8 70.7 ± 5.1 71.5 ± 6.4 0.450
LV mass index (g/m2) 110.2 ± 40.1 96.0 ± 22.1 123.0 ± 47.8 < 0.001
LA diameter (mm) 43.0 ± 6.1 39.6 ± 5.0 46.1 ± 5.3 < 0.001
E (cm/sec) 79.4 ± 23.7 76.1 ± 21.0 82.3 ± 25.8 0.168
A (cm/sec) 84.8 ± 23.5 80.5 ± 21.8 88.6 ± 24.4 0.068
E/A ratio 1.0 ± 0.4 1.0 ± 0.4 0.9 ± 0.3 0.549
DT (ms) 201.3 ± 40.7 197.7 ± 29.6 204.6 ± 48.6 0.364
S’ (cm/sec) 7.0 ± 1.3 7.2 ± 1.4 6.9 ± 1.3 0.136
E' (cm/sec) 6.1 ± 1.6 6.4 ± 1.7 5.8 ± 1.3 0.033
E/E’ratio 13.6 ± 4.6 12.1 ± 3.0 14.9 ± 5.4 0.001
Diastolic dysfunction
- Abnormal relaxation 72 (64.9) 32 (61.5) 40 (67.8) 0.491
- Pseudonormalization 39 (35.1) 20 (38.5) 19 (32.2)
Data are expressed as number (percentage) or mean ± standard deviation.
P values are for comparisons between 2 groups.
A = peak late diastolic velocity of mitral inflow; DT = deceleration time; E = peak early diastolic velocity of mitral inflow; E’ = tissue Doppler peak early diastolic
velocity of medial mitral annulus; IVSd = interventricular septum wall thickness during diastole; LA = left atrium; LAVI = left atrial volume index; LV = left ventricle;
LVDD = left ventricular end-diastolic diameter; LVSD = left ventricular end-systolic diameter; LVEDV = left ventricular end-diastolic volume; LVESV = left ventricular
end-systolic volume; S’ = tissue Doppler peak systolic velocity of medial mitral annulus.
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ROC analysis (AUC= 0.69 (95% CI: 0.59 to 0.80)). Fur-
thermore, the patients were classified as either having or
not having LA enlargement and categorized into 2 groups
according to the cutoff value of LAV index of 29 ml/m2.Table 3 Exercise parameters of all patients and the compariso
enlargement
Variables Total (n = 111) LAVI < 29
Rest HR (beats/min) 70.7 ± 14.4 74
Peak HR (beats/min) 137.2 ± 24.5 145
Rest SBP (mmHg) 145.6 ± 19.3 139
Peak SBP (mmHg) 209.4 ± 40.9 204
Rest DBP (mmHg) 79.7 ± 12.8 78
Peak DBP (mmHg) 87.9 ± 18.7 86
Rate-pressure products 28566.9 ± 8300.4 29515
Exercise duration (minutes) 6.8 ± 2.1 7
Exercise capacity (METs) 7.7 ± 1.9 8
Exercise capacity > 7 METs 73 (65.8) 4
Data are expressed as mean ± standard deviation and number (percentage).
P values are for comparisons between the 2 groups.
DBP = diastolic blood pressure; HR = heart rate; LAVI = left atrial volume index; METsClinical characteristics, echocardiographic and exercise
parameters in patients with and without LA enlarge-
ment are shown in Tables 1, 2 and 3, respectively. LAV in-
dex correlated with exercise capacity (r = −0.33, p < 0.001)
(Figure 1).ns between patients with and without left atrial
ml/m2 (n = 52) LAVI ≥ 29 ml/m2 (n = 59) P-value
.4 ± 15.7 67.5 ± 12.5 0.012
.1 ± 22.0 130.1 ± 24.5 0.001
.9 ± 17.9 150.5 ± 19.4 0.003
.7 ± 38.8 213.5 ± 42.6 0.258
.1 ± 13.4 81.0 ± 12.3 0.236
.8 ± 17.2 88.8 ± 20.1 0.583
.1 ± 7832.7 27731.2 ± 8671.9 0.282
.4 ± 1.8 6.3 ± 2.1 0.005
.3 ± 1.7 7.3 ± 2.0 0.005
3 (82.7) 30 (50.8) < 0.001
=metabolic equivalents; SBP = systolic blood pressure.
Table 4 Clinical, exercise and echocardiographic parameters of all patients and the comparisons between patients with
and without good exercise capacity
Variables Total (n = 111) Exercise capacity < 7 METs (n = 38) Exercise capacity ≥ 7 METs (n = 73) P-value
Age (years) 58.1 ± 9.2 61.7 ± 9.2 56.3 ± 8.7 0.003
Male gender 60 (54.1) 20 (52.6) 40 (54.8) 0.828
BMI (kg/m2) 25.7 ± 3.8 27.1 ± 4.0 24.9 ± 3.4 0.004
Rest HR (beats/min) 70.7 ± 14.4 70.8 ± 15.5 70.7 ± 14.0 0.975
Peak HR (beats/min) 137.2 ± 24.5 127.3 ± 23.2 142.3 ± 23.7 0.002
LVDD (mm) 48.2 ± 4.8 49.0 ± 5.5 47.8 ± 4.4 0.238
LVSD (mm) 27.9 ± 5.3 28.4 ± 6.3 27.6 ± 4.6 0.457
IVSd (mm) 10.9 ± 2.6 11.6 ± 3.1 10.5 ± 2.2 0.053
LVEDV (ml) 68.8 ± 16.6 71.7 ± 19.9 67.2 ± 14.4 0.175
LVESV (ml) 20.2 ± 8.0 21.4 ± 9.5 19.5 ± 7.0 0.220
LV ejection fraction (%) 71.1 ± 5.8 70.8 ± 6.4 71.3 ± 5.5 0.644
LV mass index (g/m2) 110.2 ± 40.1 124.4 ± 55.4 103.1 ± 27.2 0.032
LA diameter (mm) 43.0 ± 6.1 45.8 ± 5.2 41.7 ± 6.0 0.001
E (cm/sec) 79.4 ± 23.7 82.9 ± 24.1 77.6 ± 23.5 0.261
A (cm/sec) 84.8 ± 23.5 93.1 ± 24.7 80.5 ± 21.8 0.006
E/A ratio 1.0 ± 0.4 0.9 ± 0.3 1.0 ± 0.4 0.221
DT (ms) 201.3 ± 40.7 205.5 ± 48.8 199.1 ± 35.9 0.438
S’ (cm/sec) 7.0 ± 1.3 6.8 ± 1.3 7.2 ± 1.3 0.101
E' (cm/sec) 6.1 ± 1.6 5.6 ± 1.2 6.3 ± 1.7 0.007
E/E’ratio 13.6 ± 4.6 15.2 ± 5.5 12.7 ± 3.8 0.006
LAVI (ml/m2) 31.4 ± 10.5 36.3 ± 12.8 28.8 ± 8.0 0.002
Data are expressed as number (percentage) or mean ± standard deviation.
P values are for comparisons between 2 groups.
A = peak late diastolic velocity of mitral inflow; BMI = body mass index; DT = deceleration time; E = peak early diastolic velocity of mitral inflow; E’ = tissue Doppler
peak early diastolic velocity of medial mitral annulus; HR = heart rate; IVSd = interventricular septum wall thickness during diastole; LA = left atrium; LAVI = left
atrial volume index; LV = left ventricle; LVDD = left ventricular end-diastolic diameter; LVSD = left ventricular end-systolic diameter; LVEDV = left ventricular end-
diastolic volume; LVESV = left ventricular end-systolic volume; METs =metabolic equivalents ; S’ = tissue Doppler peak systolic velocity of medial mitral annulus.
Table 5 Univariate and multivariate logistic regression







Age 0.93 (0.88 to 0.98) 0.004 0.94 (0.89 to 0.99) 0.018
Body mass
index
0.85 (0.76 to 0.95) 0.005 0.82 (0.72 to 0.93) 0.002
Peak heart
rate
1.03 (1.01 to 1.05) 0.003 -
A 0.98 (0.96 to 0.99) 0.009 -
E’ 1.42 (1.06 to 1.91) 0.018 -
E/E’ ratio 0.89 (0.81 to 0.97) 0.009 -
LA dimension 0.88 (0.81 to 0.95) 0.001 -
LV mass index 0.99 (0.98 to 0.99) 0.015 -
LAVI 0.93 (0.88 to 0.97) 0.001 0.92 (0.87 to 0.97) 0.003
A = peak late diastolic velocity of mitral inflow; CI = confidence interval;
E = peak early diastolic velocity of mitral inflow; E’ = tissue Doppler peak early
diastolic velocity of medial mitral annulus; LA = left atrium; LAVI = left atrial
volume index; LV = left ventricle; OR = odd ratio.
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The present study emphasizes the importance of LAV
index as an independent echocardiographic predictor of
exercise capacity in patients with dyspnea of unknown
origin. Among several echocardiographic variables of dia-
stolic function, A, E’, E/E’ and LAV index correlated sig-
nificantly with exercise capacity. Interestingly, LAV index
was found to be the only echocardiographic measure of
diastolic function that represents an independent pre-
dictor of exercise capacity in this population.
Diastolic dysfunction and exercise capacity
Dyspnea on exertion or reduced exercise capacity is a
major clinical problem in patients with LV diastolic dys-
function, more pronounced in diastolic heart failure. It
is well known that LV diastolic dysfunction is common
in patients with LV systolic dysfunction and Doppler
variables of LV diastolic filling are better than LV sys-
tolic indices in predicting exercise capacity in patients
with systolic heart failure [9,10]. Similarly, the corre-
lations between the echocardiographic parameters of
Figure 1 Correlation of left atrial volume (LAV) index with exercise capacity.
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onstrated in patients with isolated diastolic dysfunction
[6,7,11,17-20]. Previous studies in patients with diabetes
mellitus and hypertension showed that maximum exer-
cise capacity was lower in those with diastolic dysfunction
than in control subjects without diastolic dysfunction
[17,18]. Several studies in patients with diastolic dysfunc-
tion, including the present study, demonstrated the strong
and inverse association between exercise capacity/dur-
ation and some echocardiographic parameters of LV dia-
stolic dysfunction, such as high E/E’ or LA enlargement
[7,8,19,20]. Among several measurable variables of dia-
stolic dysfunction used to predict exercise capacity, LAV
has been demonstrated as the most reliable and robust
since its size correlates closely with an impaired LV filling
and reflects the chronicity and severity to diastolic dys-
function [11]. Arruda AL et al. reported that LAV index
negatively correlated with exercise capacity and the correl-
ation was strongest in patients with isolated diastolic dys-
function as compared to those with systolic dysfunction
or control subjects [19]. The findings of the present study
were consistent with those of previous studies and dem-
onstrated that the larger LAV index was independently as-
sociated with exercise intolerance.
Left atrial enlargement as a biomarker of poor exercise
capacity
LA enlargement commonly occurs in the setting of LV
diastolic dysfunction, is associated with the presence of
cardiovascular disease and has been shown to be a poor
prognostic indicator of adverse cardiovascular outcomes,
such as atrial fibrillation, heart failure, stroke, and death[11-14]. In the absence of LV systolic dysfunction, pul-
monary hypertension, significant valvular disease or pe-
ricardial disease, patients with LV diastolic dysfunction
commonly present with dyspnea on exertion or limited
exercise capacity, presumably due to elevated pulmonary
capillary pressure and LV filling pressure [21]. It is well
known that correlations exist between exercise capacity
and Doppler-derived indices of LV diastolic dysfunction,
such as Doppler transmitral flow velocities and TDI of
the mitral annulus [5-8,18,19,21]. However, data regard-
ing LAV in predicting exercise capacity are more limited.
The echocardiographic measurement of LAV is simple
and may better reflect the severity and cumulative ef-
fect of LV filling pressure over longer time rather than
Doppler-derived LV diastolic indices alone. Pritchett
AM et al. reported in a study of the general population
that LAV index was closely associated with the severity
of diastolic dysfunction assessed by Doppler echocardiog-
raphy [14]. The mechanism of LA enlargement in patients
with isolated diastolic dysfunction is less convincing, but
it has been hypothesized that diastolic dysfunction occurs
as a consequence of cardiovascular diseases, such as LV
hypertrophy from hypertension, and leads to chronic dia-
stolic atrial pressure overload. Ultimately, LA enlargement
and symptom of dyspnea are evident in patients with iso-
lated diastolic dysfunction. Also, LA enlargement becomes
a reliable indicator of advanced diastolic dysfunction, re-
gardless of LV systolic function, underlying cardiovascular
disease or LV hypertrophy [14]. Previous studies have em-
phasized the prognostic significance of LA enlargement in
different populations [11,13]. Furthermore, Tsang TS et al.
demonstrated that LAV index had a positive correlation
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cise intolerance is a common clinical problem in patients
with diastolic dysfunction, only few studies have demon-
strated the association between LA enlargement and exer-
cise capacity [19,22,23]. Previous study in patients with LV
systolic dysfunction and heart failure showed that indexed
LA diastolic and systolic size were independent predictors
of exercise capacity and cardiovascular events (cardiac
death or hospitalization for worsening heart failure),
respectively [22]. However, the authors employed LA
dimension, not LAV, in the study. LA remodeling is a
continuous process as long as cardiovascular risk factors
or diseases still persist in any individual. As chronic dia-
stolic burden and LA remodeling continue over time, LA
shape may become less spherical and LA volume may pro-
vide a more reliable and consistent representative of LA
remodeling than LA dimension [12]. In a recent study by
Vaturi M et al., LA enlargement, defined as LAV index >
42 ml/m2, was associated with poor exercise capacity [23].
However, the study was conducted in asymptomatic pa-
tients with chronic volume overload of severe mitral
regurgitation, whereas LA enlargement was expected.
Another study in patients with isolated diastolic dys-
function showed that elevated LAV was predictive of exer-
cise capacity and elevated ventilator responses, similar to
Doppler indices of diastolic function [19]. The present
study demonstrated the similar finding that LAV index
significantly correlated with exercise capacity in patients
with normal systolic function and dyspnea on exertion
of unknown origin. However, there was no correlation
among the subgroup of patients without LA enlargement.
This finding emphasized the importance of LAV index in
risk stratification for patients with dyspnea and diastolic
dysfunction, especially those with chronic diastolic dys-
function as manifested by LA enlargement. Furthermore,
recent studies have focused on the measurement of LA
function using the speckle tracking method in patients
with diastolic dysfunction [24,25] and demonstrated that
LA function was a significant correlate of exercise cap-
acity, regardless of hemodynamic response to stress, in a
large group of patients with preserved LV ejection fraction
undergoing exercise echocardiography [25].
Study limitations
The present study has some limitations; including the
relatively small sample size and the lack of complete car-
diopulmonary exercise testing. Although the measure-
ment of maximal oxygen consumption with direct gas
exchange may be more accurate in the assessment of exer-
cise capacity, the calculation of achieved METs is widely
accepted for determining function capacity in routine clin-
ical practice and has been shown to predict long term
mortality in a large group of patients [1]. There is the po-
tential for a referral bias that the study population may bethose who seek medical attention and have more co-
morbidities than general population. The present study
was not conducted in patients undergoing exercise stress
echocardiography, but instead compared rest echocardio-
graphic parameters with exercise capacity in patients un-
dergoing echocardiography and treadmill exercise test.
The immediate post-exercise echocardiographic variables
may be a better predictor of exercise capacity, but were
not available in the present study. The study employed the
positive result of treadmill exercise testing and the echo-
cardiographic detection of regional wall motion abnorma-
lity, not the coronary angiogram as a gold standard, to
exclude coronary artery disease. Finally, more recent data
on LA function using speckle tracking have been pub-
lished and revealed promising results [24,25]. The tech-
nique has not yet been introduced to day-to-day practice
in the echocardiographic laboratory and the measurement
of LA function was not performed in the present study.
However, the role of LA function, in addition or combin-
ation with LAV, in predicting exercise capacity or clinical
outcomes warrants further study.Conclusions
In patients with isolated diastolic dysfunction and exer-
tional dyspnea, increased LAV index, a marker of chronic
diastolic dysfunction, is associated with poor exercise ca-
pacity. Therefore, LAV index should be assessed as a part
of routine echocardiographic examination and LA en-
largement may become a part of clinical risk stratification
in patients presented with exertional dyspnea.
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